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Abstract 21 
Standardising a dual x-ray absorptiometry (DXA) protocol is thought to provide a reliable 22 
measurement of body composition.  23 
Purpose: We investigated the effects of manipulating muscle glycogen and creatine content 24 
independently and additively on DXA estimates of lean mass.  25 
Method: Eighteen well-trained male cyclists undertook a parallel group application of 26 
creatine loading (n=9) (20 g/d for 5 d loading; 3 g/d maintenance) or placebo (n=9) with 27 
crossover application of glycogen loading (12 v 6 g/kg BM/d for 48 h) as part of a larger 28 
study involving a glycogen-depleting exercise protocol. Body composition, total body water, 29 
muscle glycogen and creatine content were assessed via DXA, bioelectrical impedance 30 
spectroscopy and standard biopsy techniques. Changes in the mean were assessed using the 31 
following effect-size scale: >0.2 small, >0.6, moderate, >1.2 large and compared with the 32 
threshold for the smallest worthwhile effect of the treatment.  33 
Results: Glycogen loading, both with and without creatine loading, resulted in substantial 34 
increases in estimates of lean body mass (mean ± SD; 3.0 ± 0.7 % and 2.0 ± 0.9 %) and leg 35 
lean mass (3.1 ± 1.8 %and 2.6 ± 1.0 %) respectively. A substantial decrease in leg lean mass 36 
was observed following the glycogen depleting condition (-1.4 ± 1.6 %).   Total body water 37 
showed substantial increases following glycogen loading (2.3 ± 2.3 %), creatine loading (1.4 38 
± 1.9 %) and the combined treatment (2.3 ± 1.1 %).   39 
Conclusions: Changes in muscle metabolites and water content alter DXA estimates of lean 40 
mass during periods in which minimal change in muscle protein mass is likely.  This 41 
information needs to be considered in interpreting the results of DXA-derived estimates of 42 
body composition in athletes.  43 
Introduction 44 
Dual x-ray absorptiometry (DXA) is recognised as a criterion technique for the measurement 45 
of body composition and has become a routine part of the preparation and monitoring of 46 
athletes (29).  Strategies which improve the precision of measurement can have real-life 47 
importance in sports nutrition; we have previously shown that the use of a standardised 48 
protocol which allowed the detection of small but worthwhile changes in total lean body mass 49 
and body fat that would have otherwise been missed if measured under non-standardised 50 
conditions (28).  Although the current recommendations for standardizing DXA scanning 51 
protocols aim to reduce the error/variability associated with gastrointestinal content from 52 
recent meals, general hydration status and fluid shifts associated with exercise (25, 27), we 53 
have proposed that alteration of intramuscular solutes (e.g., glycogen, creatine, carnosine) 54 
and their associated water binding may cause another source of biological variation.  Indeed, 55 
even with the implementation of a Best Practice Protocol, we sometimes observe within-56 
athlete differences in lean body mass estimates of up to 2 kg over an acute time frame, which 57 
are unlikely to be explained by real changes in muscle mass.  58 
It has previously been shown that changes in cellular substrates achieved by common 59 
practices in sports nutrition can cause detectable changes in muscle size and mass.  For 60 
example, an investigation using Magnetic Resonance Imaging (MRI) showed increases in 61 
muscle cross-sectional area following a carbohydrate loading diet (30).  Similarly, a 10-day 62 
creatine loading protocol in untrained individuals was shown to increase body mass and DXA 63 
estimates of lean body mass (35).  A recent study reported an increase in the DXA estimate of 64 
lean mass in healthy males following the intake of a  high carbohydrate in the three days prior 65 
to a DXA scan (34).  However,  how the variety of changes in muscle solutes and water 66 
content commonly experienced by athletes interact to alter estimates of muscle mass has not 67 
been considered. Therefore, it is of interest to undertake a systematic investigation of the 68 
variability in DXA measurements of body composition that can be attributed to acute changes 69 
in muscle creatine, glycogen and their effect on total body water.  We undertook such an 70 
investigation, within a larger study of creatine and glycogen loading, with the aim of further 71 
refining Best Practice Protocols for body composition assessment by DXA and/or allowing 72 
better interpretation of the results.  We hypothesized that activities that increased muscle 73 
solutes and water would create an artefact in measurement of body composition by increasing 74 
the estimate of lean body mass, while depletion would be associated with a decrease in the 75 
estimate of lean mass.  76 
 77 
Methods 78 
Participants: 79 
Eighteen competitive male cyclists (age 31.4 ± 5.6 yr; body mass 78.2 ± 8.8 kg; height 182.7 80 
± 7.2 cm; VO2max 65.2 ± 7.1 ml/kg/min) participated in this study which was approved by 81 
the human research ethics committees of the Australian Institute of Sport (20140612) and the 82 
Australian Catholic University (2014 254N).  Participants were informed of protocols and 83 
risks of the study before providing written informed consent.  84 
Study Design: 85 
This study, which was part of a larger investigation of creatine and glycogen loading on 86 
cycling performance, employed a parallel group design to investigate the effect of creatine 87 
loading, followed by a within-group cross-over application of carbohydrate loading. 88 
All participants underwent baseline measurements on day 0, followed by tests in the 89 
Glycogen Depleted state on day 1.  Following Day 1 measurements, participants were 90 
randomized into either the creatine loading or placebo group and returned for two subsequent 91 
testing days one week apart (day 7 and day 14) (see fig 1). 92 
Creatine and Glycogen Loading: 93 
Creatine loading was achieved by intake of 20 g/d of creatine monohydrate (Musashi 94 
Creatine Monohydrate, Vitaco, NSW, Australia) for five days using a split dose regimen (4 x 95 
5 g/d, consumed at the same time as a carbohydrate-containing meal or snack) followed by 96 
creatine maintenance (3 g/d) (13).  Normalised glycogen stores were achieved by consuming 97 
a pre-packaged diet providing a carbohydrate intake (6 g/kg/d) for 48 hr as well as imposing a 98 
standardised training protocol including a rest day prior to the DXA scan. Meanwhile, 99 
glycogen loading was achieved by providing a pre-packaged diet providing 12 g/kg/d of 100 
carbohydrate for the same standardised time period (5).  Hydration status was standardised by 101 
implementing a standardised fluid intake for the 24 h period prior to the DXA scans.  102 
Glycogen depletion was achieved by undertaking a cycling protocol in the laboratory lasting 103 
~ 3 h 30 min, with consumption of a pre-packaged low carbohydrate diet following 104 
completion of the protocol until the next morning’s DXA scan.  105 
The achievement of these protocols provided scenarios to reflect normal-creatine normal-106 
glycogen (Baseline; n = 18), normal-creatine glycogen-depleted (n = 18; Glycogen Depleted), 107 
creatine-loaded glycogen-loaded (n=9; Creatine-Glycogen Loaded), normal-creatine 108 
glycogen-loaded (n = 9; Glycogen Loaded), and creatine-loaded normal-glycogen (n = 9; 109 
Creatine Loaded). 110 
Dietary Standardisation: 111 
An individualised two day menu was constructed for each participant using FoodWorks 112 
Professional Edition, Version 7.0 (Xyris Software, Brisbane, Australia) based on their body 113 
mass and food preferences.  Prior to the baseline trial, subjects received a moderate-114 
carbohydrate diet providing 6 g.kg-1BM/d carbohydrate; 1.5 g/kg/BM/d protein; 1.5 g/kg-115 
/BM/d fat, with a total energy goal of ~215 kJ/kg/BM per day.  The participants were then 116 
randomised to receive either a repeat of the moderate-carbohydrate diet (6g.kg-1BM/d) or a 117 
carbohydrate-loading diet (12 g/kg/BM/d) in the two days prior to the Glycogen Loaded and 118 
Glycogen Normal trials (Day 7 and Day14) in a cross-over allocation.  These dietary 119 
treatments were implemented using a placebo-controlled design, whereby the overall menu 120 
for the day was kept constant, but key items were provided either as a low-kilojoule/low 121 
carbohydrate option or an indistinguishable carbohydrate-enriched/high kilojoule.   Protein 122 
and fat intake each remained constant at 1.5 g/kg/BM/d in these diets, but energy intake was 123 
increased in the carbohydrate-loading diet (~320 kJ/kg/d).  Participants refrained from any 124 
intake of alcohol during the dietary standardisation period.  Caffeine and fluid intake was 125 
allowed ad lib two days prior to the baseline trial and up to two standard serves (e.g. 1 cup of 126 
coffee or 1 can caffeinated soft drink) the day before the experimental trial.  Participants 127 
recorded their caffeine and fluid intake and this was repeated during the dietary 128 
standardisation period of subsequent trials.  Following the glycogen depleting exercise (Day 129 
0), participants were fed a pre-packaged standardised low carbohydrate diet (<1 g/kg/BM) for 130 
the reminder of the day to minimise resynthesis of muscle glycogen stores. Subjects were 131 
provided with all foods and most of their fluids in a standardised menu in portion controlled 132 
packages, and were given verbal and written instructions on how to follow the diet.    133 
Checklists were used to record each menu item as it was consumed, and to note any 134 
deviations from the menu.  An analysis of all the actual diets consumed by participants was 135 
undertaken on completion of the study using the same software. 136 
Muscle Biopsy:  137 
Each participant underwent 4 biopsies over the course of the study, with each being collected 138 
from the same leg from an incision that was as least 2 cm from the previously biopsied site.  139 
All biopsies were conducted by medical practitioners using a 5-mm Bergstrom needle 140 
modified with suction (9). The site was anesthetised using 1% xylocaine prior to an incision 141 
being made through the dermal layer and facia on the quadriceps.  Muscle tissue was 142 
immediately frozen in liquid nitrogen and stored at -80°C for later analysis.  143 
Biochemical Analysis: 144 
Muscle creatine and glycogen concentrations were measured as described previously (6, 12). 145 
Glycogen concentrations were determined via enzymatic analysis with fluorometric detection 146 
(Jasco FP-750 spectroﬂuorometer, Easton, MD) at excitation 365 nm/emission 455 nm. 147 
Concentrations were expressed as millimoles of glycogen per kilograms of dry weight 148 
(mmol/kg dw). Muscle tissue was analyzed in duplicate for free creatine, creatine phosphate, 149 
and adenosine triphosphate (ATP) using fluorometric techniques. Total creatine was 150 
measured as a sum of free creatine and creatine phosphate (13). 151 
DXA and Total Body Water Protocol: 152 
For each of the four different conditions, participants reported to the laboratory in the 153 
morning after an overnight fast and undertook a total body DXA scan as per a standardised 154 
protocol (29).  Body composition was assessed using a whole body scan on a narrowed fan-155 
beam DXA (Lunar Prodigy, GE Healthcare, Madison, WI) with analysis performed using GE 156 
Encore 12.30 software (GE, Madison, WI).  The DXA technical error of measurement (TEM) 157 
was ~ 0.1% for total mass, 0.4% for total lean, 1.9% for total fat and 0.7% for total bone 158 
mineral content (25).  Following 15 min of rest, total body water and fluid compartments 159 
were assessed using Bioelectrical Impedance Spectroscopy (BIS) (IMP SFB7, ImpediMed 160 
Limited, Queensland, Australia) and analysed using BioImp Analysis 5.4.0 Software 161 
(ImpediMed Limited, Queensland, Australia) according to the protocol described by Moon et 162 
al. (24). The BIS has a TEM of 0.81L. Hydration status was monitored by measurement of 163 
urine specific gravity (UG-a, Atago Refractomer, Japan) from a sample collected upon 164 
waking. 165 
Statistical Analysis: 166 
We used a mixed linear model (Proc Mixed in version 9.4 of the statistical Analysis System; 167 
SAS Institute, Cary, NC) to estimate the effect of the treatments on muscle glycogen 168 
concentration, muscle creatine concentration, the mass of each component of body and leg 169 
composition, and the mass of intracellular, extracellular and total body fluids. Treatment was 170 
a fixed effect in the model (nominal, with six levels), while random effects were the athlete 171 
identity and its interaction with dummy variables to estimate error additional to the residual 172 
(individual responses) to glycogen depletion, glycogen loading, creatine loading, and 173 
combined glycogen and creatine loading.  All dependent variables were log transformed for 174 
analysis.  The smallest important change was determined as per Nana et al. (26).  by using the 175 
default approach of standardization with an appropriate between-subject standard deviation, 176 
here the baseline standard deviation.  The magnitudes of changes the resulting effects were 177 
assessed using the following scale:, <0.2 trivial, >0.2 small, >0.6 moderate, >1.2 large (14).  178 
Small or larger changes were considered substantial when the threshold for the small effect 179 
was reached (≥0.2).  Uncertainty in the changes is shown as expressed by 90% confidence 180 
limits when the upper and lower confidence limits represented substantial increases and 181 
decreases, respectively.  Owing to the considerable number of effects investigated, the effects 182 
were assessed as clear or unclear using 99% confidence limits.  All other effects were deemed 183 
clear, and shown with the probabilities that the true effect was a substantial decrease, a trivial 184 
change, or a substantial increase. 185 
 186 
Results 187 
Baseline values and percentage changes with the different treatments are presented in a series 188 
of tables: total body composition (Table 1), leg regional body composition (Table 2), body 189 
water (Table 3) and muscle glycogen concentrations (Table 4).  190 
Body mass (Table 1):  There was a substantial increase in body mass in the combined 191 
Creatine–Glycogen Loaded treatment compared to baseline, the observed effect being small.  192 
Changes in the separate Glycogen Loaded and Creatine Loaded treatments on body mass 193 
were clearly not substantial.  Additionally, there was no substantial change in body mass 194 
following the Glycogen Depleted condition.  195 
Lean Mass (Table 1 and 2): There were  substantial increases in lean body mass following the 196 
Creatine-Glycogen Loaded and the sole Glycogen Loaded treatments compared with baseline 197 
measurements, with the observed effects being small.  Similar results were observed for leg 198 
lean mass with a small but substantial increase with both treatments. The was no substantial 199 
decrease in lean body mass following the  Glycogen Depleted condition but there was a  200 
substantial decrease in leg lean mass. The effects of the Creatine Loading condition on lean 201 
body mass and leg lean mass were likely trivial. 202 
Fat mass and Bone mass (Table 1 and 2): Compared to baseline measurements, changes in 203 
total fat mass and leg fat mass in Glycogen Depleted and Glycogen Loaded conditions were 204 
not substantial and produced trivial effect sizes relative to the smallest important effect. The 205 
effects of Creatine-Loading and the combined Creatine-Glycogen Loading conditions on total 206 
body fat mass and leg fat mass were also not-substantial.  Changes in total bone mass and leg 207 
bone mass for all treatment conditions were not substantial.  208 
Body water (Table 3):  There were likely substantial effects of Glycogen Depletion and 209 
Glycogen Loading treatments on total body water. There was a likely decrease in 210 
extracellular fluid in the Glycogen Depletion treatment.  An increase in total body water and 211 
intracellular fluid with the combined Creatine-Glycogen Loaded condition was very likely, 212 
with a possible increase in extracellular fluid.  The Creatine Loading condition was 213 
associated with a possible likely increase in total body water and intracellular fluid, but no 214 
clear effect on extracellular fluid.  215 
Muscle glycogen (Table 4):  The effects of Glycogen Depletion, Glycogen Loading and the 216 
combined Creatine-Glycogen loading treatments on muscle glycogen concentration were 217 
clear.  There was no clear effect of the Creatine Loading treatment on muscle glycogen 218 
concentrations.  219 
 220 
Discussion 221 
This study is the first to systematically investigate the effect of glycogen loading, creatine 222 
loading and their interaction on DXA estimates of body composition.  Estimates of lean body 223 
mass were substantially higher with glycogen loading translating to a mean 1.3 kg increase in 224 
lean body mass and 1.7 kg increase in leg lean mass following our glycogen loading 225 
treatment and a 1.9 kg increase in lean body mass and 2.0 kg increase in leg lean mass 226 
following a combined creatine glycogen loading treatment.  On the other hand, glycogen 227 
depleting exercise resulted in a mean decrease of 1.0 kg and 0.8kg of lean body mass and leg 228 
lean mass which was deemed very likely trivial. The changes in the DXA estimates of lean 229 
body mass and leg lean mass were reflected by the changes in total body water and 230 
intracellular fluid. Our findings of increased total body water, and more specifically 231 
intracellular fluid, with glycogen loading were expected.  However, we have demonstrated, 232 
for the first time that this creates an artefact in DXA-derived measurements of body 233 
composition in well trained athletes.  234 
It is well accepted that water is bound to the glycogen molecule in the cellular environment.  235 
Indeed, a ratio of three grams of water to one gram of muscle glycogen is commonly stated, 236 
based primarily on a single rat study from the 1940s which determined that 1 g of liver 237 
glycogen was associated with 2.7 g of water over a range of concentrations (23). Olsson and 238 
colleagues assessed body water by tritium trace in dilution in males before and after glycogen 239 
loading, reporting that each gram of glycogen was stored with 3-4 g of water (31). They 240 
observed a mean increase in body mass of 2.4 kg, of which 2.2 L was attributed to the 241 
increase in total body water. (31).  However, Sherman et al. completed studies of rat skeletal 242 
muscle and failed to find a consistent relationship between glycogen and water content over a 243 
range of glycogen concentrations (36). More recently, Fernández-Elías and colleagues 244 
reported different ratios of muscle glycogen to water following post-exercise glycogen 245 
repletion under different fluid intakes.  A ratio of 1:3 was found when only 400 ml of water 246 
was consumed, while a ratio of 1:17 was determined when participants replaced the fluid lost 247 
during exercise (10).  Although anecdotes and studies have noted that glycogen loading is 248 
associated with a gain in total body mass (4), and that changes in glycogen can confound the 249 
results of weight loss programs in the general community (19), few studies have investigated 250 
how changes in glycogen loading (and consequently body water) would affect interpretations 251 
of body composition in athlete populations.  252 
 253 
An increase in body mass is considered a direct side effect of the creatine supplementation 254 
during the initial loading phase (15, 16, 38).  The mass increase is often attributed to water 255 
retention, as five days is considered too short a period to detect real changes in myofibrillar 256 
protein content (15, 16, 32, 38). Since creatine is an osmotic particle, increases in its 257 
concentration in muscle could induce cellular swelling leading to fluid retention (2, 11). 258 
Indeed, acute decreases in urinary output (15) and increases in total body and intracellular 259 
water have both been reported following creatine loading protocols. Furthermore, creatine 260 
supplementation of 20-25 g per day for 5-7 days has been associated with increases of 1.0 to 261 
2.0 kg (18, 37, 38) in body mass and 1.3 to 2.3 L in total body water (7, 32, 35).  However, 262 
not all studies have found a concurrent increase in the intracellular water compartment (32).   263 
 264 
To our knowledge, only a handful of studies has have investigated the effect of carbohydrate 265 
loading or creatine loading on body composition or muscle size (1, 30, 34), and we are the 266 
first to investigate the interaction of these two strategies. Another novel aspect of our study 267 
was the assessment of total body water as an adjunct to the measurement of body 268 
composition; to our knowledge, no other study has reported on the effect of glycogen loading 269 
on lean body mass and total body water. Our findings support those of Nygren et al. (30) and 270 
Rouillier et al. (34), with substantial increases in muscle glycogen, lean body mass and total 271 
body water observed following 48 h of glycogen loading.  Nygren et al. (30) reported an 272 
increase in the vastus lateralis cross sectional area by MRI following four days of 273 
carbohydrate loading in healthy males. The increase in muscle cross sectional area was 274 
attributed to the increase in glycogen (281 to 634 mmol/kg/dw) along with the binding of the 275 
water (30).  However, neither body water nor measures of body composition were assessed in 276 
this investigation.  Meanwhile Balon and colleagues found no increase in muscle girth 277 
following a three day high carbohydrate diet (80% carbohydrate) compared with a low 278 
carbohydrate diet (10% carbohydrate) with concurrent resistance training (1).  279 
 280 
A recent study investigating three days of increased carbohydrate intake on DXA estimates of 281 
body composition reported a mean 0.9 kg increase in lean body mass and 1.4 kg increase in 282 
appendicular lean mass (arms and legs) (34). Although the authors attributed the increase in 283 
appendicular lean mass to increased glycogen storage, no biopsies were conducted to verify 284 
changes in muscle glycogen content (34). Furthermore, dietary intake was not prescribed and 285 
although carbohydrate intake achieved the stated goal of exceeding 75% of total energy 286 
intake, this amounted to a total daily intake of 8 g/kg, compared to 12g/kg in our study.  287 
Some concerns regarding the standardization of the methodology of the DXA scans are also 288 
noted: although not clearly stated, the DXA scans were conducted following an overnight rest 289 
and fast (3) but it is unknown whether carbohydrate intake was standardized prior to the 290 
baseline scan.  291 
 292 
Several studies have investigated the effect of creatine supplementation on body composition, 293 
however they are often for longer supplementation periods and taken concurrently with 294 
resistance training (2, 8, 11, 20, 39).  Currently only one other study has assessed the sole 295 
effect of short term creatine supplementation on body water and body composition (35). 296 
Safdar et al. reported increases in lean body mass by DXA following a 10 day creatine 297 
supplementation period in untrained individuals (35).  Furthermore, measurement of total 298 
body water by BIS revealed an increase in intracellular fluid compartment, although the 299 
magnitude of this increase was not provided (35). Our creatine loading treatment resulted in 300 
only trivial changes in muscle creatine content and lean mass, and showed only possible 301 
increases in total body water and intracellular fluid.  Due to our study design, the assessment 302 
of all these parameters occurred on either Day 7 or Day 14 of the supplementation protocol, 303 
where participants had changed to a reduced creatine dosage (3 g/d), believed to maintain 304 
elevated creatine stores (33), for two or nine days respectively.  However, since van Loon et 305 
al. (37) recently reported that this “maintenance” dose is not always sufficient for maintaining 306 
creatine levels, it is possible that a reduction in creatine content occurred over the longer 307 
maintenance period, obscuring any earlier effects.  308 
 309 
We note some other real and apparent limitations of this study.  Due to the requirements of 310 
the larger study, we were unable to add further measurements such as an assessment of body 311 
composition and body water under a creatine loaded-glycogen depleted condition.  312 
Furthermore, we anticipate the criticism that the glycogen depleted condition was monitored 313 
15-18 h after the completion of the glycogen-depleting task.  However, as we conducted our 314 
scans using a standardised protocol based on Nana et al. (28) which require fasted and rested 315 
conditions to standardize gut contents and hydration status, we needed to undertake these 316 
measurements on the morning following the exercise session.  However, we attempted to 317 
minimize glycogen resynthesis during the recovery period by providing participants with a 318 
diet providing < 1 g/kg carbohydrate.  This was successful in maintaining glycogen content 319 
below pre-exercise levels, and indeed may mirror the real-life practices of athletes who “sleep 320 
low” (restrict carbohydrate intake) after quality training sessions to prolong the adaptive 321 
response to exercise by delaying muscle glycogen storage (21).  We acknowledge that BIS is 322 
an indirect measurement of total body water, however, the use of the criterion dilution 323 
methods did not fit within the constraints of the larger study. Additionally, BIS has been 324 
recently validated against criterion methods in athletes and was considered appropriate in this 325 
setting (17, 22).   326 
 327 
In summary, the results from this study provide further evidence of daily variability in the 328 
DXA assessments of body composition of athletes due to factors frequently experienced in 329 
sport.  Recent work by our centre has developed techniques to standardize DXA assessment 330 
protocols (25, 27, 28), showing that the implementation of overnight fasted and rested 331 
conditions can reduce variability to allow greater sensitivity in the detection of real and 332 
interesting changes in body composition (28).  The present study expands on this work and 333 
indicates that when DXA is used for longitudinal monitoring of physique, scans should be 334 
undertaken with consideration of recent practices of training and diet that might be expected 335 
to manipulate muscle glycogen stores.  Where standardization of these practices is 336 
impractical, the interpretation of the results of DXA assessments of body composition should 337 
take into account the likely artefacts with respect to lean mass.  Future studies should also 338 
investigate the effect of other sources of changes in intramuscular fluid and substrate such as 339 
muscle damage or carnitine supplementation, alongside those caused by exercise or dietary 340 
manipulation.   341 
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Table 1. Baseline values, smallest important change, and percent changes from baseline following 
various treatments for total body composition. Also shown are magnitude-based inferences for the 
mean changes with each treatment.   
  Change (%) from baseline (mean; ±CL) 
Measure 
Baseline 
(mean ± SD) SIE 
Glycogen 
Depleted 
Glycogen 
Loaded 
Creatine 
Loaded 
Creatine-
Glycogen 
Loaded 
Body mass 77 ± 9 kg 2.3 -1.3; ±0.3  2.1; ±0.7  1.2; ±0.5  2.8; ±0.5 ↑** 
DXA whole body mass    
Total 78 ± 8 kg 2.2 -1.3; ±0.3  2.3; ±0.6 ↑* 1.3; ±0.6  3.0; ±0.5 ↑*** 
Lean 84 ± 6 %BM 1.5 -1.3; ±0.3  2.1; ±0.5 ↑** 1.3; ±0.5 3.0; ±0.4 ↑*** 
Fat 12 ± 6 %BM 8.6 -2.0; ±1.5  4.5; ±3.4  3.3; ±5.7  5.2; ±3.9  
Bone 4.2 ± 0.3 %BM 1.8 -0.2; ±0.5  0.4; ±1.1  0.0; ±0.5  -0.2; ±0.5  
%BM, percent of baseline body mass; CL, 90% confidence limits;  
SIE, smallest important effect. This is 0.2 of the between subject SD and the percent change a variable 
has to meet to be considered a substantial change; ↑ indicates substantial increase; ↓, indicates 
substantial  decrease;   
Asterisk/s indicates how clear the change is at the 99% confidence level, *possible clear change, 
**likely clear change, ***very or likely clear change. 
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Table 2. Baseline values, smallest important change, and percent changes from baseline following 
various treatments for regional leg composition. Also shown are magnitude-based inferences for the 
mean changes with each treatment. 
  Change (%) from baseline (mean; ±CL) 
Measure 
Baseline 
(mean ± SD) SIE 
Glycogen 
Depleted 
Glycogen 
Loaded 
Creatine 
Loaded 
Creatine-
Glycogen 
Loaded 
Total 35.3 ± 2.0 %BM 1.1 -1.4; ±0.6 ↓** 2.9; ±0.8 ↑*** 1.1; ±1.2 ↑* 2.9; ±1.3 ↑*** 
Lean 29.4 ± 2.3 %BM 1.5 -1.4; ±0.7 ↓* 2.6; ±0.8 ↑*** 1.2; ±1.0  3.1; ±1.2 ↑*** 
Fat 4.3 ± 2.5 %BM 8.5 -2.5; ±1.7  6.2; ±1.8  2.4; ±6.1  3.2; ±4.1  
Bone 1.65 ± 0.15 %BM 2.0 0.0; ±0.3  0.7; ±0.5  -0.2; ±0.7  -0.2; ±0.5  
%BM, percent of baseline body mass; CL, 90% confidence limits;  
SIE, smallest important effect. This is 0.2 of the between subject SD and the percent change a variable 
has to meet to be considered a substantial change; ↑ indicates substantial increase; ↓, indicates 
substantial  decrease;   
Asterisk/s indicates how clear the change is at the 99% confidence level, *possible clear change, 
**likely clear change, ***very or likely clear change. 
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Table 3. Baseline values, smallest important change, and percent changes from baseline following 
various treatments for total body water and water compartments. Also shown are magnitude-based 
inferences for the mean changes with each treatment. 
  Change (%) from baseline (mean; ±CL) 
Measure 
Baseline 
(mean ± SD) SIE 
Glycogen 
Depleted 
Glycogen 
Loaded 
Creatine 
Loaded 
Creatine-
Glycogen 
Loaded 
Total 
body 61.2 ± 3.8 %BM 1.3 -2.0; ±1.1 ↓** 2.3; ±1.3 ↑** 1.3; ±1.7 ↑* 2.5; ±1.0 ↑*** 
Intra-
cellular 36.1 ± 3.0 %BM 1.4 -1.3; ±1.6 ↓* 2.2; ±1.9 ↑* 1.4; ±2.0 ↑* 6.8; ±4.5 ↑*** 
Extra-
cellular 25.3 ± 1.4 %BM 1.0 -3.5; ±1.2 ↓*** 2.2; ±1.5 ↑** 0.3; ±1.8 1.4; ±1.9 ↑* 
%BM, percent of baseline body mass; CL, 90% confidence limits;  
SIE, smallest important effect. This is 0.2 of the between subject SD and the percent change a variable 
has to meet to be considered a substantial change; ↑ indicates substantial increase; ↓, indicates 
substantial  decrease;   
Asterisk/s indicates how clear the change is at the 99% confidence level, *possible clear change, 
**likely clear change, ***very or likely clear change. 
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Table 4. Baseline values, smallest important change, and percent changes from baseline following 
various treatments for muscle glycogen and total creatine. Also shown are magnitude-based inferences 
for the mean changes with each treatment. 
  Change from baseline (mean; ± CL) 
Measure 
Baseline 
(mean ± SD) SIE 
Glycogen 
Depleted 
Glycogen 
Loaded 
Creatine 
Loaded 
Creatine-
Glycogen Loaded 
Muscle 
Glycogen 
580 ± 140 
mmol/kg dw 1.9 -57; ±7.3 ↓*** 22; ±12.6 ↑*** -2; ±15.4 20; ±15.9 ↑*** 
Muscle 
Creatine 
136 ± 17 
µmol/g 2.2 0; ±6.2 -2; ±8.5 6; ±10.1 6; ±4.6 ↑** 
%BM, percent of baseline body mass; CL, 90% confidence limits;  
SIE, smallest important effect. This is 0.2 of the between subject SD and the percent change a variable 
has to meet to be considered a substantial change; ↑ indicates substantial increase; ↓, indicates 
substantial  decrease;   
Asterisk/s indicates how clear the change is at the 99% confidence level, *possible clear change, 
**likely clear change, ***very or likely clear change. 
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Figure 1: Overivew of study design. Pla: Placebo, Cr: Creatine, CHO: Carbohydrate, TT: 466 
time trial. 467 
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